Tenderwize
Zurück zur Suche

Colistin Discount Agreement (Open-House)

AOK Niedersachsen. Die Gesundheitskasse.·Hannover, Germany·Deadline Jun 27, 2027 · 306 days left·Open·Supplies·Framework
Structured notice only
Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Colistin (ATC-Code: J01XB01).

40/100

Opportunity Score

Needs reviewLow complexity
SuppliesFrameworkOpen
Warum diese Bewertung?

Chance

40 / 100

Komplexität

20 / 100

Risikofaktoren

The open-house contracts can be terminated automatically without notice when exclusive agreements are awarded (expected...

No minimum purchase or volume commitment. The agreement is only a discount framework; actual sales depend on prescripti...

No procurement documents available

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Moderate opportunity

Wichtige Fakten

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Aug 2027
  • Conclusion of non-exclusive discount agreements for Colistin (ATC J01XB01) with pharmaceutical companies.
  • Open-house model with standardized contract terms and conditions.
Vollständige Zusammenfassung anzeigen

This notice announces a non-exclusive discount agreement (Rabattvertrag) for the active substance Colistin (ATC J01XB01) under § 130a Abs. 8 SGB V, following an 'open-house' model. The AOK Niedersachsen invites all interested pharmaceutical companies to conclude standardized discount contracts without a competitive selection process. The contract runs from 01.09.2025 to 31.08.2027, with potential monthly entry and early termination if exclusive contracts are awarded. No estimated value is provided. The notice explicitly states this is not a public procurement under EU directives but is published for transparency.

Risiken

The open-house contracts can be terminated automatically without notice when exclusive agreements are awarded (expected...

No minimum purchase or volume commitment. The agreement is only a discount framework; actual sales depend on prescripti...

No procurement documents available

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

  • Must be a pharmaceutical entrepreneur as defined in § 4 Abs. 18 AMG with respect to the offered medicinal products.
  • Must have a seat in Germany, another EU member state, or an EEA state (§ 9 Abs. 2 Satz 1 AMG).

Administrative

  • Submission of contract documents in paper form (electronic submission not allowed).

Anforderungen können unvollständig sein.

Zuschlagskriterien

Lot 1

Award based solely on price (discount offered).

Auftraggeber

Lose (1)

LOT-0000

Colistin Discount Agreement (Open-House)

Non-exclusive discount contract for Colistin (ATC J01XB01) with standardized terms. Pharmaceutical companies can join at any time, subject to the maximum contract period ending 31.08.2027. Contracts may be replaced by exclusive agreements awarded later.

SuppliesFrameworkEU fundedElectronic submission

Ort

DE929, Germany

Dauer

Aug 2025 - Aug 2027

Kategorie

Pharmaceutical products

Zuschlagskriterien

Price

Frist

Deadline Jun 27, 2027

Vergabedetails

Veröffentlichungsdatum
08 Jul 2025
Sprachen
German

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
447775-2025

Ähnliche Ausschreibungen